J Am Board Fam Med 2012;25:367382
They are supplied strictly as reference materials for in-vitro laboratory research and are not medicines, foods, supplements or cosmetics
Individuals managing chronic gut issues like IBS, IBD, or leaky gut Those seeking ongoing wellness maintenance rather than immediate results Anyone looking for general inflammation control and systemic support Individuals who prefer a slow-release option to support daily function and recovery By targeting the intestines more directly, Delayed BPC-157 is particularly helpful for those with digestive sensitivity or those using the peptide for internal inflammation rather than muscular or skeletal pain
Using long-read sequencing and advanced AI algorithms, NEO7 maps your genetic and metabolic pathways to design personalized peptides that repair cellular signaling, optimize mitochondrial performance, and correct gene expression errors
For example, more than 30% of patients using GLP-1 therapies for obesity discontinue within the first month and nearly 60% stop within three months, underscoring the importance of identifying and prioritizing potential high-risk periods for proactive monitoring and targeted intervention, if needed
